SIMIAN T-CELL LEUKEMIA-VIRUS TYPE-I FROM NATURALLY INFECTED FERAL MONKEYS FROM CENTRAL AND WEST-AFRICA ENCODES A 91-AMINO ACID P12 (ORF-I) PROTEIN AS OPPOSED TO A 99-AMINO ACID PROTEIN ENCODED BY HTLV TYPE-I FROM HUMANS
Nk. Saksena et al., SIMIAN T-CELL LEUKEMIA-VIRUS TYPE-I FROM NATURALLY INFECTED FERAL MONKEYS FROM CENTRAL AND WEST-AFRICA ENCODES A 91-AMINO ACID P12 (ORF-I) PROTEIN AS OPPOSED TO A 99-AMINO ACID PROTEIN ENCODED BY HTLV TYPE-I FROM HUMANS, AIDS research and human retroviruses, 13(5), 1997, pp. 425-432
A single protein of 12 kDa, p12 is encoded by the HTLV-I genome from b
oth the singly spliced mRNA pX-ORF-I and doubly spliced mRNA pX-rex-OR
F-I, While many full-length sequences of HTLV-1 are known, data on the
p12 region of African STLV-I are unavailable. We have undertaken to s
equence the p12 gene in STLV-I from Central and West African naturally
infected primates, and have compared them to known p12 sequences of H
TLV-I, Our data on sequence and in vitro transcription-translation ana
lyses indicate that p12 is a 91-amino acid (aa) protein among STLV-I s
trains from Central and West Africa, in contrast to the 99-aa protein
found among HTLV-I strains around the globe, The p12 sequences of STLV
-I exhibit a marked genetic variability at the level of both nucleotid
e and peptide sequences. Hydropathic and helical wheel analyses reveal
that 60% of residues in HTLV-I p12 are hydrophobic, in contrast to 55
% in STLV-I from Africa. Although HTLV-I and STLV-I show a similar put
ative antigenic site, a second potential site was located exclusively
in STLV-I from Africa, There are differences in the predicted transmem
brane domains in p12 between STLV-I and HTLV-I, Furthermore, the secon
dary structure data according to the Chou and Fasman algorithm predict
an alpha-helical domain at the carboxy terminus in HTLV-I, and this:
domain may be truncated in STLV-I p12, The amino acid sequence of p12
shows two leucine zipper moths (LZMs) at the amino terminus and in the
middle region, respectively, This is the first report describing the
size differences in p12 protein between HTLV-I and STLV-I, which may p
rovide insights into pathogenic mechanisms used by HTLV-I and STLV-I.